The Oral Antidiabetic Drugs Market size is expected to grow at an annual average of 3% during 2021-2027. Oral diabetes medications are the most widely used method on the market, with many players bringing different products to market. For example, in August 2015, Glenmark Pharmaceuticals Limited launched generic tenerigliptin, a third-generation oral antidiabetic treatment. Awareness […]
